GATA1 Gene Polymorphisms in Down Syndrome Patients

Objectives: Down syndrome (DS) patients have a 500 fold higher possibility of developing acute megakaryoblastic leukemia (AMKL), compared with the general population. GATA1 mutations, acquired in the early prenatal stages, contributes to leukemogenesis in AMKL and has been the explanation for the ca...

Full description

Bibliographic Details
Published in:	Central Asian Journal of Medical Sciences
Main Authors:	Kherlen Ponkhoon, Uranchimeg Bayarmagnai, Sarantuya Jav, Munkhtuya Tumurkhuu
Format:	Article
Language:	English
Published:	Mongolian National University of Medical Sciences 2017-06-01
Subjects:	down syndrome gata1 transcription factor acute megakaryoblastic leukemia single nucleotide polymorphism
Online Access:	https://www.mongoliajol.info/index.php/CAJMS/article/view/2708

Similar Items

Quality of Life and Its Associated Factors among Caregivers of Down Syndrome Children
by: Kherlen Ponkhoon, et al.
Published: (2018-09-01)

Down syndrome presenting with different hematological manifestations: A case series of four cases
by: Darilin Shangpliang, et al.
Published: (2020-01-01)

Pediatric Acute Megakaryoblastic Leukemia with a GATA2 Mutation and Monosomy 7: A Case Report and Clinical Management Challenges
by: Gowri Joshi, et al.
Published: (2025-08-01)

Advances in molecular characterization of myeloid proliferations associated with Down syndrome
by: Jixia Li, et al.
Published: (2022-08-01)

Features of acute megakaryoblastic leukemia diagnosis in a child with Down syndrome
by: N. K. Guskova, et al.
Published: (2023-03-01)

Profile of down syndrome–associated malignancies: Epidemiology, clinical features and therapeutic aspects
by: Akira Shimada
Published: (2021-06-01)

Transient abnormal myelopoiesis with extramedullary involvement in a down syndrome preemie leading to an unresponsive course despite chemotherapy
by: Saroja Devi Geetha, et al.
Published: (2023-01-01)

Acute panmylelosis with myelofibrosis - A rare case report with review of literature
by: Surbhi Dahiya, et al.
Published: (2025-01-01)

Acute Megakaryoblastic Leukemia with t(1;22) Mimicking Neuroblastoma in an Infant
by: Müge Gökçe, et al.
Published: (2015-02-01)

Hypercalcemia and diffuse osteolytic lesions in a 45-year-old patient with myeloid sarcoma with megakaryocytic differentiation
by: Aditya Goud, et al.
Published: (2016-04-01)

Adult acute megakaryoblastic leukemia with persistent diarrhea and extreme thrombocytosis: A very unusual case
by: Nevin Alayvaz Aslan, et al.
Published: (2024-04-01)

Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy
by: Yee J, et al.
Published: (2019-05-01)

Strain-dependent modifiers exacerbate familial leukemia caused by GATA1-deficiency
by: Ikuo Hirano, et al.
Published: (2024-02-01)

Clinical Courses of Two Pediatric Patients with Acute Megakaryoblastic Leukemia Harboring the CBFA2T3-GLIS2 Fusion Gene
by: Mayu Ishibashi, et al.
Published: (2016-11-01)

Effects of metformin on proliferation and apoptosis of human megakaryoblastic Dami and MEG-01 cells
by: Xue Liang, et al.
Published: (2017-09-01)

Aberrant GATA2 Activation in Pediatric B-Cell Acute Lymphoblastic Leukemia
by: Han Wang, et al.
Published: (2022-01-01)

Evolution of Developmental GATA Factors in Nematodes
by: Ethan Eurmsirilerd, et al.
Published: (2020-11-01)

Modeling Down Syndrome Myeloid Leukemia by Sequential Introduction of <i>GATA1</i> and <i>STAG2</i> Mutations in Induced Pluripotent Stem Cells with Trisomy 21
by: Sonali P. Barwe, et al.
Published: (2022-02-01)

Diagnosis and Treatment of Pediatric Acute Megakaryoblastic Leukemia with NUP98::KDM5A Rearrangement: Case Report
by: Hyemin Kang, et al.
Published: (2024-10-01)

CBFA2T3::GLIS2‐positive acute leukemia with RAM and mixed T/megakaryocytic phenotype
by: Mahsa Khanlari, et al.
Published: (2023-08-01)

Liver fibrosis among infants with t(1;22)(p13;q13) acute megakaryoblastic leukemia: a case report and literature review
by: Nira Arad-Cohen, et al.
Published: (2024-08-01)

Hepatic myeloid sarcoma preceding acute megakaryoblastic leukemia with t(1;22) in an infant: Case report
by: Zeynep Canan Özdemir, et al.
Published: (2016-10-01)

Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia
by: Carina Maria Pinto, et al.
Published: (2024-10-01)

Deciphering the Landscape of GATA-Mediated Transcriptional Regulation in Gastric Cancer
by: Rodiola Begolli, et al.
Published: (2024-10-01)

Detection of transient abnormal myelopoiesis blasts in a liver biopsy specimen by double-immunostaining for full-length GATA1 and CD42b
by: Azusa Haba, et al.
Published: (2023-12-01)

Clinical characterization and genetic analysis of transient abnormal myelopoiesis without the down syndrome phenotype
by: Junpeng Cai, et al.
Published: (2025-03-01)

Rare Case of Germline GATA2‐Deficiency With Merkel Cell Carcinoma and Acute Myeloid Leukemia
by: SooHo Yu, et al.
Published: (2024-12-01)

KLK2 single-nucleotide polymorphism rs198977 is associated with increased susceptibility and hyperleukocytosis in AML
by: Guangqiang Meng, et al.
Published: (2023-08-01)

Down syndrome‐associated transient abnormal myelopoiesis with placental involvement
by: Yahya Daneshbod, et al.
Published: (2022-11-01)

The role of the APE1 Asp148Glu polymorphism on the risk of acute myeloid leukemia in Iraqi patients
by: Thamer Mouhi Jasiem, et al.
Published: (2024-04-01)

miR-1202 acts as anti-oncomiR in myeloid leukaemia by down-modulating GATA-1S expression
by: Raffaele Sessa, et al.
Published: (2024-02-01)

The RBM39 degrader indisulam inhibits acute megakaryoblastic leukemia by altering the alternative splicing of ZMYND8
by: Ying Yang, et al.
Published: (2025-04-01)

Prenatal diagnosis of Down syndrome combined with transient abnormal myelopoiesis in foetuses with a GATA1 gene variant: two case reports
by: Hui Tang, et al.
Published: (2023-10-01)

FOXP3 and GATA3 Polymorphisms, Vitamin D3 and Multiple Sclerosis
by: Concetta Scazzone, et al.
Published: (2021-03-01)

Transient Abnormal Myelopoiesis in a Down Syndrome Baby: A Case Report
by: Vani Krishnamurthy, et al.
Published: (2024-08-01)

Germline Single-Nucleotide Polymorphism <i>GFI1-36N</i> Causes Alterations in Mitochondrial Metabolism and Leads to Increased ROS-Mediated DNA Damage in a Murine Model of Human Acute Myeloid Leukemia
by: Jan Vorwerk, et al.
Published: (2025-01-01)

The role of GATA2 in adult hematopoiesis and cell fate determination
by: Iris J. A. Peters, et al.
Published: (2023-11-01)

ADRB2 and ACE Gene Polymorphisms in COPD Susceptibility
by: Chimedlkhamsuren Ganbold, et al.
Published: (2016-11-01)

Immune checkpoint‐related gene polymorphisms are associated with acute myeloid leukemia
by: Yuyan Wu, et al.
Published: (2023-09-01)

Acute Kidney Injury in Myeloid Leukemia of Down Syndrome: Risk Factors and Outcomes
by: Chompoonut Limratchapong, et al.
Published: (2023-03-01)